{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:53:34Z","timestamp":1792061614615,"version":"4.4.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":3334,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chinese Medical Sciences Journal"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.24920\/j1001-9242.2007.003","type":"journal-article","created":{"date-parts":[[2017,6,4]],"date-time":"2017-06-04T21:42:46Z","timestamp":1496612566000},"page":"22-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Efficacy and Safety of SGLT2 Inhibitors in Patients with Type 1 Diabetes: A Meta-analysis of Randomized Controlled Trials"],"prefix":"10.1016","volume":"32","author":[{"given":"Yingying","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.24920\/J1001-9242.2007.003_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/dmrr.1141","article-title":"The changing epidemiology of type 1 diabetes: why is it going through the roof?","volume":"27","author":"Vehik","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"10.24920\/J1001-9242.2007.003_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-med-051013-110046","article-title":"The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus","volume":"66","author":"Vallon","year":"2015","journal-title":"Annu Rev Med"},{"key":"10.24920\/J1001-9242.2007.003_bib3","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/ijcp.12698","article-title":"Comparative efficacy and safety of antidiabetic drug regimens added to stable and inadequate metformin and thiazolidinedione therapy in type 2 diabetes","volume":"69","author":"Saulsberry","year":"2015","journal-title":"Int J Clin Pract"},{"key":"10.24920\/J1001-9242.2007.003_bib4","first-page":"1","article-title":"Diabetes mellitus. Report of a WHO Study Group","volume":"727","year":"1985","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.24920\/J1001-9242.2007.003_bib5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2337\/dc13-2955","article-title":"Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study","volume":"38","author":"Henry","year":"2015","journal-title":"Diabetes Care"},{"key":"10.24920\/J1001-9242.2007.003_bib6","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/dom.12494","article-title":"Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4-week, randomized, placebo-controlled trial (EASE-1)","volume":"17","author":"Pieber","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.24920\/J1001-9242.2007.003_bib7","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2337\/dc14-2806","article-title":"Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, as adjunct therapy to insulin in type 1 diabetes","volume":"38","author":"Sands","year":"2015","journal-title":"Diabetes Care"},{"key":"10.24920\/J1001-9242.2007.003_bib8","first-page":"676191","article-title":"Case reports that illustrate the efficacy of SGLT2 inhibitors in the type 1 diabetic patient","volume":"2015","author":"Bell","year":"2015","journal-title":"Case Rep Endocrinol"},{"key":"10.24920\/J1001-9242.2007.003_bib9","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3949\/ccjm.80a.13053","article-title":"Canagliflozin: improving diabetes by making urine sweet","volume":"80","author":"Vouyiouklis","year":"2013","journal-title":"Cleve Clin J Med"},{"key":"10.24920\/J1001-9242.2007.003_bib10","doi-asserted-by":"crossref","first-page":"c365","DOI":"10.1136\/bmj.c365","article-title":"The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews","volume":"340","author":"Kirkham","year":"2010","journal-title":"BMJ"},{"key":"10.24920\/J1001-9242.2007.003_bib11","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1177\/147323001204000408","article-title":"Relationship between fasting and 2-hour postprandial plasma glucose levels and vascular complications in patients with type 2 diabetes mellitus","volume":"40","author":"Tanaka","year":"2012","journal-title":"J Int Med Res"},{"key":"10.24920\/J1001-9242.2007.003_bib12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S2213-8587(13)70050-0","article-title":"SGLT inhibitors in management of diabetes","volume":"1","author":"Tahrani","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.24920\/J1001-9242.2007.003_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jama.2016.9400","article-title":"Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis","volume":"316","author":"Palmer","year":"2016","journal-title":"JAMA"},{"key":"10.24920\/J1001-9242.2007.003_bib14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/MED.0000000000000239","article-title":"The changing therapeutic armamentarium for patients with type 1 diabetes","volume":"23","author":"Comee","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.24920\/J1001-9242.2007.003_bib15","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1517\/14740338.2015.1100167","article-title":"SGLT2 inhibition: efficacy and safety in type 2 diabetes treatment","volume":"14","author":"Scheen","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"10.24920\/J1001-9242.2007.003_bib16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/2042018815575273","article-title":"Glucuretic effects and renal safety of dapagliflozin in patients with type 2 diabetes","volume":"6","author":"Hinnen","year":"2015","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.24920\/J1001-9242.2007.003_bib17","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4158\/EP161292.PS","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the association of SGLT-2 inhibitors and diabetic ketoacidosis","volume":"22","author":"Handelsman","year":"2016","journal-title":"Endocr Pract"}],"container-title":["Chinese Medical Sciences Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1001929417300159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1001929417300159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/cmsj.cams.cn\/CN\/article\/downloadArticleFile.do?attachType=PDF&id=356","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:30:28Z","timestamp":1792060228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1001929417300159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1001929417300159"],"URL":"https:\/\/doi.org\/10.24920\/j1001-9242.2007.003","relation":{},"ISSN":["1001-9294"],"issn-type":[{"value":"1001-9294","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of SGLT2 Inhibitors in Patients with Type 1 Diabetes: A Meta-analysis of Randomized Controlled Trials","name":"articletitle","label":"Article Title"},{"value":"Chinese Medical Sciences Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.24920\/J1001-9242.2007.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 Chinese Academy Medical Sciences. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}